Table 2 Hazard ratios for cardiovascular events and deaths in the alfacalcidol group based on both ALP and PTH.
Subgroups | Fatal and non-fatal CV events | All-cause mortality | CV events and mortality | ||||
|---|---|---|---|---|---|---|---|
iPTH | ALP | HR* [95% CI] | P-value | HR* [95% CI] | P-value | HR* [95% CI] | P-value |
46 pg/mL | 183 U/L | 1.54 [0.91–2.60] | 0.11 | 0.99 [0.58–1.70] | 0.98 | 1.14 [0.75–1.72] | 0.54 |
234 U/L | 1.33 [0.82–2.16] | 0.25 | 0.89 [0.53–1.49] | 0.65 | 1.03 [0.68–1.55] | 0.90 | |
296 U/L | 1.18 [0.69–2.01] | 0.54 | 0.90 [0.51–1.59] | 0.71 | 1.00 [0.64–1.57] | 0.99 | |
85 pg/mL | 183 U/L | 1.38 [0.90–2.11] | 0.14 | 1.20 [0.76–1.88] | 0.44 | 1.15 [0.82– 1.62] | 0.43 |
234 U/L | 1.16 [0.80–1.66] | 0.44 | 0.99 [0.67–1.45] | 0.94 | 0.99 [0.73–1.35] | 0.97 | |
296 U/L | 1.08 [0.72–1.61] | 0.71 | 0.93 [0.61–1.43] | 0.74 | 0.97 [0.69–1.35] | 0.85 | |
129 pg/mL | 183 U/L | 1.22 [0.66– 2.27] | 0.52 | 1.47 [0.75–2.89] | 0.26 | 1.16 [0.70–1.92] | 0.56 |
234 U/L | 0.99 [0.62–1.57] | 0.96 | 1.11 [0.68–1.82] | 0.67 | 0.96 [0.66–1.40] | 0.82 | |
296 U/L | 0.98 [0.59–1.63] | 0.93 | 0.97 [0.56–1.68] | 0.91 | 0.94 [0.62–1.42] | 0.76 | |
